ImmunoForge Expands Drug Development Licensing Agreement with Duke University
The elastin-like polypeptide (ELP) platform acquired by ImmunoForge was developed by Dr. Ashutosh Chilkoti (BME, Pratt).
Duke Capital Partners Leads Investment in Reselute
Reselute, founded around Duke technology by a Duke professor and graduates, is developing solutions to orthopedic infections
Duke University celebrates World Intellectual Property Day 2023
Duke University is ranked 18th in the Top 100 Worldwide Universities Granted Utility Patents by the National Academy of Inventors.
Ai-RGUS wins Security Industry Association award
Ai-RGUS is a Duke start-up spun up from technology developed by Drs. Jordan Malof, Leslie Collins, Joseph Camilo, and Daniel Reichman (ECE, Pratt).
Managing Academic Software Projects for Licensing
Software projects have multiple possible intellectual property and licensing paths – Duke University experts can help guide your digital innovation journey.
Tune Therapeutics Strengthens Leadership Team with Addition of Dr. Derek Jantz as Chief Scientific Officer and Zachary Hale as General Counsel
Tune Therapeutics is an epigenomic editing start-up spun out of the lab of Dr. Charles Gersbach (BME, Pratt).
Ginkgo Bioworks Strengthens End-to-End R&D Capabilities in Gene Therapy through Acquisition of StrideBio’s AAV Capsid Discovery and Engineering Platform Assets
StrideBio was co-founded by Dr. Aravind Asokan (Surgery, SOM) and the company entered into sponsored research and licensing agreements for technology developed in his Duke lab.
Duke Capital Partners Leads Investment in Lacuna Medical
Lacuna Medical is Developing a 3D Shape Catheter that is More Resistant to Failure
Evecxia Therapeutics Reports Favorable Data From a Phase 1 Single Ascending Dose Safety/Tolerability/PK/PD Trial of EVX-301
Evecxia Therapeutics is a Duke University start-up, founded by inventors Drs. Jacob Jacobsen and Marc Caron (Cell Biology, SOM) around their serotonin synthesis amplification therapeutic technology for mental health applications.